These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38533136)

  • 21. Correlation of Computed Tomography (CT) Severity Score With Laboratory and Clinical Parameters and Outcomes in Coronavirus Disease 2019 (COVID-19).
    Pamulapati BK; Nanjundappa RK; Chandrabhatla BS; Roohi SU; Palepu S
    Cureus; 2024 Jan; 16(1):e52324. PubMed ID: 38361692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disease Outcomes of COVID-19 in Diabetic and Hypertensive Patients During the Hospital Stay.
    Abid A; Umar A; Qamar S
    Cureus; 2023 Oct; 15(10):e46943. PubMed ID: 38022228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the Impact of Inflammatory Markers and CT Severity Score on Disease Severity of COVID-19 Patients Admitted to ICU at a Tertiary Hospital.
    Kurri N; Tyagi B; Singhal E; Gupta N; Agarwal AK; Gupta V; Rai G; Bindra MS
    J Assoc Physicians India; 2021 Jun; 69(6):11-12. PubMed ID: 34472783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
    Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
    J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of Severity in Covid-19 Patients in Casablanca, Morocco.
    El Aidaoui K; Haoudar A; Khalis M; Kantri A; Ziati J; El Ghanmi A; Bennis G; El Yamani K; Dini N; El Kettani C
    Cureus; 2020 Sep; 12(9):e10716. PubMed ID: 33033687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Variants, Characteristics, and Outcomes Among COVID-19 Patients: A Case Series Analysis at a Tertiary Care Hospital in Karachi, Pakistan.
    Ahsan T; Rani B; Siddiqui R; D'Souza G; Memon R; Lutfi I; I Hasan O; Javed R; Khan F; Hassan M
    Cureus; 2021 Apr; 13(4):e14761. PubMed ID: 34084685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective Analysis of Inflammatory Markers and Patient Characteristics in Hospitalized Covid-19 Patients: An Early Experience in Louisiana.
    Miatech JL; Yaslik CP; Tarleton HE; West D; Kellum W; McKnight M; Stagg MP
    Cureus; 2020 Sep; 12(9):e10257. PubMed ID: 33042695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.
    Huang CY; Tsai HW; Liu CY; Liu TH; Huang HL; Chang CC; Chen WC; Sun JT
    Chin J Physiol; 2021; 64(6):306-311. PubMed ID: 34975124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum biomarker panel for disease severity and prognosis in patients with COVID-19.
    Li J; Tang M; Liu D; Xie Z; Wang F; Yang Y
    J Clin Lab Anal; 2023 Jan; 37(2):e24831. PubMed ID: 36604799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.
    Sharma A; Sharma C; Raina S; Singh B; Dadhwal DS; Dogra V; Gupta S; Bhandari S; Sood V
    Trials; 2021 Jul; 22(1):451. PubMed ID: 34266452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NEUROPROTECTIVE AND ANTIOXIDANT POTENTIAL OF MONTELUKAST-ACETYLCYSTEINE COMBINATION THERAPY FOR BRAIN PROTECTION IN PATIENTS WITH COVID-19 INDUCED PNEUMONIA.
    Samsonia M; Kandelaki M; Baratashvili N; Gvaramia L
    Georgian Med News; 2023 Feb; (335):111-118. PubMed ID: 37042600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
    Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
    PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.
    Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H
    J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Biochemical Markers in Invasive Ventilation of Coronavirus Disease 2019 Patients: Multinomial Regression and Survival Analysis.
    Asghar MS; Haider Kazmi SJ; Khan NA; Akram M; Jawed R; Rafaey W; Hassan M; Rasheed U; Khan M; Khan AR
    Cureus; 2020 Aug; 12(8):e10054. PubMed ID: 32999777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between acute phase reactants and prognosis in patients with or without COVID-19 pneumonia.
    Sayit AT; Elmali M; Deveci A; Gedikli O
    Rev Inst Med Trop Sao Paulo; 2021; 63():e51. PubMed ID: 34190953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 Infection-Dependent Modulation in Vital Components of the Serum Profile of Severely SARS-CoV-2 Infected Patients.
    Izhari MA
    Infect Drug Resist; 2024; 17():1653-1667. PubMed ID: 38707987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].
    Chen L; Liu HG; Liu W; Liu J; Liu K; Shang J; Deng Y; Wei S
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):203-208. PubMed ID: 32164089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.